Profound Medical (TSE:PRN)

Profound Medical (PRN) Income Statement


Profound Medical Income Statement

Last quarter (Q4 2023), Profound Medical's total revenue was $2.01M, an increase of 59.82% from the same quarter last year. In Q4, Profound Medical's net income was $-8.91M. See Profound Medical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 16
Total Revenue
$ 7.20M$ 7.20M$ 6.68M$ 6.87M$ 7.30M$ 0.00
Cost of Revenue
$ 2.82M$ 2.82M$ 3.66M$ 3.92M$ 3.83M$ 0.00
Gross Profit
$ 4.38M$ 4.38M$ 3.02M$ 2.95M$ 3.47M$ 0.00
Operating Expense
$ 33.57M$ 33.57M$ 32.33M$ 33.24M$ 22.34M$ 11.64M
Operating Income
$ -29.19M$ -29.19M$ -29.31M$ -30.29M$ -18.86M$ -11.64M
Net Non Operating Interest Income Expense
$ 872.00K$ 872.00K$ 629.00K$ 310.00K$ 149.00K$ -498.62K
Other Income Expense
$ 378.00K$ 378.00K$ 275.00K$ 7.00K$ -2.86M-
Pretax Income
$ -28.70M$ -28.70M$ -28.38M$ -30.59M$ -21.58M$ -12.14M
Tax Provision
$ -128.00K$ -128.00K$ 287.00K$ 105.00K$ 45.00K$ 10.46K
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -28.57M$ -28.57M$ -28.67M$ -30.70M$ -21.62M$ -12.15M
Basic EPS
$ 0.51$ 1.35$ 1.38$ -1.50$ -1.25$ -2.90
Diluted EPS
$ 0.16$ 1.35$ 1.38$ -1.50$ -1.25$ -2.90
Basic Average Shares
$ 84.73M$ 21.18M$ 20.83M$ 20.46M$ 17.29M$ 4.15M
Diluted Average Shares
$ 84.73M$ 21.18M$ 20.83M$ 20.46M$ 17.29M$ 4.15M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 28.10M$ 36.39M-$ -37.16M$ 26.17M$ 11.64M
Net Income From Continuing And Discontinued Operation
$ -28.57M$ -28.57M$ -28.67M$ -30.70M$ -21.62M$ -12.15M
Normalized Income
$ -23.74M$ -28.82M$ -18.34M$ -22.49M$ -19.52M$ -12.15M
Interest Expense
----$ 543.00K$ 615.87K
$ -27.93M$ -27.93M$ -28.21M$ -30.53M$ -21.03M$ -11.52M
$ -26.92M$ -26.64M$ -28.50M$ -28.65M$ -19.50M$ -11.38M
Currency in USD

Profound Medical Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis